NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
Clinical Trials
79 trialsNCT04037254 2026-03-16
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Phase 1/2 Completed
NCT01596816 2026-03-13
CKNO-PRO
Centre Oscar Lambret
Phase 2 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT07464964 2026-03-11
MUSIC-PRT
Dokuz Eylul University
Phase NA Completed
NCT05162846 2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT00160979 2026-03-06
Transrectal Tumour Oxygen - US Army
University Health Network, Toronto
Phase 2 Completed
NCT01546987 2026-03-06
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01567800 2026-03-06
Prostate Hypoxia FAZA
University Health Network, Toronto
Phase NA Completed
NCT05764005 2026-03-06
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT00063882 2026-03-05
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT05008900 2026-03-05
TOPP
University Health Network, Toronto
Phase 2 Completed
NCT05999968 2026-03-05
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Eli Lilly and Company
Phase 1 Completed
NCT07448545 2026-03-05
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
Completed
NCT06472856 2026-03-04
VASA Pro
University College Cork
Phase NA Completed
NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT04443062 2026-02-27
Bullseye
Radboud University Medical Center
Phase 2 Completed
NCT04736199 2026-02-27
ARANOTE
Bayer
Phase 3 Completed
NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
NCT01171898 2026-02-24
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Aragon Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT01314118 2026-02-24
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Janssen Biotech, Inc.
Phase 2 Completed
NCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
NCT03388619 2026-02-23
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02899221 2026-02-20
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Thomas Jefferson University
Phase NA Completed
NCT04461509 2026-02-20
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT04815876 2026-02-20
PREVENT2
Weill Medical College of Cornell University
Phase NA Completed
NCT00809991 2026-02-18
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04048252 2026-02-18
PROSTED
Centre Hospitalier Universitaire de Nīmes
Completed
NCT06235099 2026-02-18
Solar-Recur
Curium US LLC
Phase 3 Completed
NCT07416812 2026-02-18
IMPACT
Institute of Oncology Ljubljana
Phase NA Completed
NCT07417475 2026-02-18
Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction
Ankara University
Phase NA Completed
NCT02776436 2026-02-17
REDEX
Leiden University Medical Center
Phase 1 Completed
NCT03421782 2026-02-17
Fatigue Interventions in Cancer (Exercise Intervention)
University of Utah
Phase 2 Completed
NCT04397276 2026-02-17
A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
Janssen Research & Development, LLC
Phase 1 Completed
NCT06661902 2026-02-17
BURN
University of Washington
Phase 1/2 Completed
NCT07413120 2026-02-17
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Incheon St.Mary's Hospital
Phase 3 Completed
NCT01543659 2026-02-13
Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02274779 2026-02-13
OLIGOPELVIS
Institut Cancerologie de l'Ouest
Phase 2 Completed
NCT02313623 2026-02-12
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Yale University
Completed
NCT06253065 2026-02-11
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT05730712 2026-02-06
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT00893035 2026-02-05
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
Institut du Cancer de Montpellier - Val d'Aurelle
Completed
NCT03707574 2026-02-04
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Completed
NCT04484246 2026-02-04
HoSAGE
Assistance Publique Hopitaux De Marseille
Completed
NCT06379880 2026-02-04
FEGALA
Centre Paul Strauss
Phase NA Completed
NCT06764992 2026-02-04
Exploring Men s Prostate Cancer Genetic Risk Perceptions
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03535831 2026-02-03
PM-PPR
University Health Network, Toronto
Phase NA Completed
NCT05701007 2026-01-29
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Completed
NCT02003924 2026-01-27
PROSPER
Pfizer
Phase 3 Completed